Dyne Therapeutics has provided a community letter with an update for their Dyne-251 Study. We encourage members of the Canadian Duchenne community to review this information carefully as it contains important updates on trial results and safety considerations.

We look forward to keeping you up to date as this progresses and more updates become available. Read the full letter below.

Want to know more about Duchenne Research?

Scientists and medical experts have been tirelessly pursuing diverse approaches to defeat Duchenne muscular dystrophy. From tackling the root cause to alleviating symptoms, the field of research is vast and promising. Explore the various strategies being developed and tested, and gain insights into the future of muscular dystrophy treatment: